DavidBrownMD
Ophthalmology • Houston, TXRetinal Disease
Clinical Instructor, Ophthalmology, Baylor College of Medicine
Dr. Brown is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6560 Fannin St
Ste 750
Houston, TX 77030Phone+1 713-524-3434Fax+1 713-524-3220- Is this information wrong?
Education & Training
University of Iowa Hospitals and ClinicsResidency, Ophthalmology, 1990 - 1995
Baylor College of MedicineInternship, Transitional Year, 1988 - 1988- Baylor College of MedicineClass of 1987
Certifications & Licensure
TX State Medical License 1989 - 2025
LA State Medical License 1996 - 2006
IA State Medical License 1989 - 1997- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
- Super Doctor SuperDoctors.com
- Fellow (FAAO) American Academy of Ophthalmology
- Join now to see all
Clinical Trials
- Pilot Study of X-82 in Patients With Wet AMD Start of enrollment: 2012 Oct 01
- Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion Start of enrollment: 2012 Oct 01
- A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema Start of enrollment: 2013 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Suprachoroidal Space Injection Technique: Expert Panel Guidance.Cunningham, E., Ciulla, T., Wykoff, C., Avery, R., Barakat, M., Boyer, D., Brown, D., Brucker, A., Heier, J., Holekamp, N., Kaiser, P., Khanani, A., Kim, J., Demirci, ...> ;Retina. 2024 Mar 5
- 10 citationsEffect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical Trial.Charles C Wykoff, David M Brown, Kimberly Reed, Alyson J Berliner, Adam T Gerstenblith, Aurora Breazna, Prema Abraham, Jordana G Fein, Karen W Chu, W Lloyd Clark, Serg...> ;JAMA Ophthalmology. 2023 Sep 1
- 4 citationsKESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema.Charles C Wykoff, Justus G Garweg, Carl Regillo, Eric Souied, Sebastian Wolf, Dilsher S Dhoot, Hansjuergen T Agostini, Andrew Chang, Augustinus Laude, Joachim Wachtlin...> ;American Journal of Ophthalmology. 2024 Apr 1
- Join now to see all
Press Mentions
Kodiak Sciences Announces Emerging Durability Data from Ongoing Phase 1b Study of KSI-301 in Wet AMD Patients at the Retina Society Annual MeetingSeptember 15th, 2019
Kodiak Sciences to Release Durability Data from Clinical Development Program of KSI-301 for Wet AMD at the Retina Society Annual MeetingSeptember 12th, 2019
Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019- Join now to see all
Professional Memberships
- Fellow
- Member
Hospital Affiliations
Houston Methodist HospitalHouston, Texas
Memorial Hermann Southeast HospitalHouston, Texas
Memorial Hermann Physician NetworkHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
